Strong After GLP-1

Protect

Hair loss after GLP-1: what the evidence says and what helps

There is more hair in the brush than there used to be, and nobody warned you. Here is what is actually known, what is still uncertain, and how to tell ordinary shedding from something that needs an appointment.

By Samantha Munns·Published 27 July 2026·Last reviewed 27 July 2026

The short answer

  1. It is usually shedding, not balding. Diffuse thinning across the whole scalp, starting two to four months after rapid weight loss, most often settles and regrows.
  2. The evidence moved in July 2026. A BMJ study found a real but small association between GLP-1 use and recorded hair loss. Nobody has established the mechanism.
  3. Do not stop your medication over it. That is a conversation with your prescriber, not a decision for a bad week.
  4. Get seen if the pattern is wrong. Patchy loss, a widening parting, a sore scalp or shedding past six months is not ordinary weight-loss shedding.

It is in the shower drain, on the pillow, on your jumper. Your ponytail feels thinner in your hand, and every wash has quietly turned into a small act of dread.

If this started a few months into significant weight loss on a GLP-1, you are not imagining it and you are not unusual. It is one of the most common things people raise once the weight is finally coming off, and one of the least discussed beforehand.

Before anything else: do not stop, reduce or change a prescribed GLP-1 medicine because of hair loss without speaking to your prescriber.

Hair loss is one of the more common reasons people quietly abandon treatment that is otherwise working for them. That decision deserves a proper conversation, not a bad morning and a brush full of hair.

What we actually know

The new study

On 22 July 2026, The BMJ published a study using health records from the University of Pennsylvania Health System, comparing adults with type 2 diabetes starting GLP-1 receptor agonists against adults starting two other classes of diabetes medicine.1

GLP-1 use was associated with a 37% higher relative risk of recorded non-scarring hair loss compared with SGLT-2 inhibitors, and 68% higher compared with DPP-4 inhibitors.1

Those figures sound alarming until you see the absolute numbers underneath them. The recorded rates were 6.91 cases per 1,000 person-years among GLP-1 users, against 5.04 and 3.89 in the comparison groups.12 That is roughly two to three extra recorded cases per thousand people per year.

What the study cannot tell you matters as much as what it can:

  • It is observational, so it shows an association rather than proving cause.
  • Everyone in it had type 2 diabetes. It does not automatically describe someone taking a GLP-1 for weight management alone.
  • It counted diagnostic codes, so it says nothing about how severe the hair loss was, how long it lasted, or whether it recovered.
  • It could not separate the medicine from rapid weight loss, reduced eating, hormonal change or something else entirely.

The honest summary is not that GLP-1 medicines cause baldness. It is that hair loss is a real, recorded effect worth taking seriously, that the absolute risk is low, and that nobody has yet established why it happens.

What the prescribing information says

Hair loss is listed as a common side effect in the UK prescribing information for Wegovy, which in that document has a defined meaning: it affects between 1 in 100 and 1 in 10 people.3

The detail underneath is more useful than the headline. Hair loss was reported in 2.5% of people on semaglutide 2.4 mg against 1.0% on placebo, and in 5.3% of people on semaglutide 7.2 mg against 1.0% on placebo. The events were mainly mild, most people recovered while still on treatment, and hair loss was reported more often in those who lost at least 20% of their body weight.3

Mounjaro lists it at the same frequency, with one detail worth noticing. The label marks hair loss as a reaction whose frequency comes from the weight-management trials specifically, rather than the diabetes ones.4 That is the prescribing information itself pointing at where the signal shows up: the studies where the weight loss is large.

In the pooled SURMOUNT-1, -2 and -3 studies, hair loss was reported in 4.9% of people on tirzepatide against 1.0% on placebo. The events were mainly mild, most people recovered while still on treatment, and no one taking tirzepatide stopped the medication or left the study because of it.4

What regulators are seeing

The US Food and Drug Administration has said it is evaluating hair loss as a potential safety signal.1 In the UK, the MHRA has received 399 reports of hair loss linked to tirzepatide so far in 2026, following 541 last year, and 148 reports linked to semaglutide, following 164 last year.5

Those are spontaneous reports rather than measured rates, so they cannot tell you how likely this is for you. What they do tell you is that a great many people are experiencing this and saying so.

What the shedding usually looks like

Hair does not grow continuously. Most follicles are actively growing at any moment, while a smaller share are resting before shedding and starting again.

A significant physical stressor can push far more follicles than usual into the resting phase at the same time. Months later, that whole group sheds together. This is telogen effluvium, and marked weight loss and extreme dieting are recognised triggers.6

Two features explain why it feels so alarming.

It is diffuse, not patchy. The thinning spreads across the whole scalp rather than appearing as distinct bald spots. You notice volume, not gaps.

It is delayed. The shedding begins around three months after the trigger, which is why it so often starts at the point when everything else is finally going well. Your hair is responding to something that happened months ago, not to how you are doing today. That delay is also why people so frequently blame the wrong thing.

For many people that is exactly what is happening. But not every case of hair loss during GLP-1 treatment is telogen effluvium, and heavy shedding sometimes draws attention to pattern hair loss that was already developing underneath.6 A widening parting, progressive thinning at the crown or a receding hairline deserves assessment rather than being filed under weight loss and waited out.

Why it may be happening

Probably more than one thing at once.

The rate of weight loss

Marked weight loss is a physiological stressor whatever produces it, and hair shedding after bariatric surgery and crash dieting long predates these medications. The Wegovy label reporting more hair loss among people who lost at least 20% of their weight fits that picture, though it does not prove weight loss is the whole story.36

Eating much less overall

A far smaller appetite makes it harder to meet energy, protein, iron and other nutrient needs. That does not mean everyone on a GLP-1 becomes deficient. It means persistently low intake, a very narrow diet, or ongoing vomiting and gut symptoms should not be shrugged off.

Iron, thyroid, or something unrelated

Iron deficiency and thyroid conditions cause diffuse hair loss in their own right, entirely separately from anything you are taking. Depending on your symptoms, diet and history, a clinician may consider other tests too.67

A possible medicine-related effect

Hair loss appears in current semaglutide prescribing information, the BMJ study found an association, and regulators are actively looking at it. It is no longer defensible to say the medication plays no direct part. It is equally not established that it does. The evidence at present cannot separate the drug from the weight loss and the eating changes that come with it.

What helps

There is no product that reverses telogen effluvium, and no way to make a months-long hair cycle run in a fortnight. What you can do is remove ongoing triggers, protect your nutrition, and get assessed if the pattern does not fit.

1. Make eating enough easier, especially protein

Protein matters for general nutrition and for holding onto muscle during weight loss. It is not a proven treatment for hair shedding and nobody should sell it to you as one. But persistently low intake is one of the few contributing factors genuinely in your hands.

Published targets for people using weight-management medicines vary, and the right figure depends on your size, age, activity, kidney function and health, so this is worth individualising with a clinician or dietitian rather than adopting a number from the internet.89

With a small appetite, structure helps more than arithmetic:

  • a protein-rich food at every meal;
  • eat the most useful part of the plate while your appetite is freshest, which usually means the protein first;
  • keep genuinely easy options in the house for low-energy days;
  • ask for help if you are struggling to eat much at all.

If the eating side is where you keep getting stuck, the protein-first guide for a smaller appetite sets out the method in full.

2. Ask for assessment rather than guessing

Do not diagnose yourself with an iron or vitamin deficiency from symptoms and start supplementing.

A clinician may consider a full blood count, ferritin and thyroid function, and may add other tests depending on your circumstances.67 Normal results do not rule out every cause, but they narrow the picture considerably. If something is low, treat that specific thing with guidance rather than taking several high-dose supplements at once.

This is a reasonable appointment to ask for. You do not need to justify it beyond saying you have lost a significant amount of weight and are shedding hair.

3. Tell your prescriber what is actually happening

If you are still losing weight quickly, struggling to eat, vomiting often or feeling unwell, say so. Those details change the clinical picture, and they are exactly the sort of thing people leave out because they do not want to seem ungrateful for a medicine that is working.

Decisions about your dose belong with the clinician responsible for your care, not with an article.

4. Reduce avoidable breakage

Gentle handling will not change the follicle cycle, but it stops you losing more to breakage on top of the shed: looser ties instead of tight styles, less heat and harsh processing, careful detangling, no aggressive brushing.610

Free · One page · No cost

What to Ask Your GP About Hair Loss

A one-page checklist to print or screenshot and take to the appointment, so you come away with answers rather than reassurance.

  • The red flags that mean this is not ordinary weight-loss shedding
  • The tests a clinician may consider, and what each one rules in or out
  • The supplement interaction to mention before any blood test
  • Space to record dates, patterns and what you have noticed
Get the free checklist

Instant PDF · no payment details required

What to be sceptical about

Supplements promising fast regrowth

No over-the-counter product makes a months-long hair cycle run quicker. Be wary of anything selling with fear, dramatic before-and-after images or guaranteed timelines.

High-dose biotin especially

Biotin deficiency is rare, and there is limited evidence that extra biotin helps people who are not deficient.11 More importantly, high-dose biotin can interfere with laboratory tests including certain cardiac troponin and thyroid assays, producing misleading results.12 That matters at exactly the moment you are trying to get useful bloods, and in the case of troponin, potentially in an emergency. If you take a hair, skin and nails supplement, tell your clinician and the laboratory.

Anything sold as a cure for telogen effluvium

The British Association of Dermatologists notes that it normally improves without treatment, and that medication does not speed regrowth.6 That does not mean you should tolerate distressing hair loss without help. It means the priority is the right diagnosis and removing an ongoing trigger, not an expensive promise.

When to see a GP, doctor or dermatologist

Book an appointment rather than assuming this is temporary shedding if:

  • the loss is patchy, or leaving smooth, sharply defined bald areas;
  • your parting is steadily widening, the crown is progressively thinning, or your hairline is receding;
  • you are losing eyebrow or eyelash hair;
  • your scalp is sore, burning, itchy, red, scaly or inflamed;
  • the shedding is still strong beyond six months, or getting worse rather than settling;
  • it comes with other symptoms: marked fatigue, feeling unusually cold, heavy periods, or other signs of illness;
  • you are vomiting persistently or eating very little;
  • it is causing you significant distress, which is reason enough on its own.

Early assessment matters because some inflammatory and scarring conditions cause permanent loss if left untreated, and those need catching early.

How long does it last?

When the cause is acute telogen effluvium and the trigger has passed, the shedding phase commonly runs three to six months.6 Regrowth follows, but slowly, and restoring visible density takes many months more.

You will probably notice short new hairs around your hairline long before you notice any change in thickness.

That is medically reassuring and emotionally maddening. Temporary does not mean trivial, and nobody should tell you to simply be patient about something you see in the mirror every morning.

Common questions

Does Ozempic cause hair loss?

Hair loss has been reported with GLP-1 receptor agonists including semaglutide, and the 2026 BMJ study found an association in adults with type 2 diabetes.1 Association is not proof that the medicine damages follicles directly. Weight loss, nutrition and other changes may all contribute.

Is Mounjaro or Wegovy hair loss permanent?

Prescribing information for semaglutide describes events as mainly mild, with most people recovering while still on treatment.3 The BMJ study found the association was with non-scarring hair loss, where the follicle stays intact and regrowth remains possible.1 Neither is a guarantee for any individual, which is why patchy, progressive or inflamed hair loss needs proper assessment.

Will my hair grow back?

Hair usually regrows after acute telogen effluvium once the trigger has resolved.6 Hair loss from another cause may behave differently, which is why the pattern and the duration matter more than the fact of shedding.

Should I come off my GLP-1 because of it?

Not on the basis of an article. Hair loss has to be weighed against what the medicine is doing for you, your rate of weight change, your nutrition, your other symptoms and the alternative explanations. That is a conversation with your prescriber.

Does biotin help?

There is no good evidence that high-dose biotin treats shedding in someone who is not deficient, and it can interfere with important blood tests.1112

Where to start

Hair loss after GLP-1 treatment is often temporary diffuse shedding. Often is not always, and that distinction is the whole point of this page.

Three questions will tell you most of what you need:

  1. Is the loss spread across your scalp, or is it patchy or concentrating in one area?
  2. Has your overall intake, particularly protein and iron-rich food, dropped sharply?
  3. Is it settling over months, or still getting worse?

Then act on the answer. Get assessed if the pattern is unclear. Protect your eating if it has slipped. Talk to your prescriber if the weight is still coming off fast or you are struggling to eat.

Hair is one of four things that tends to slip in this phase, and it is rarely the only one. If you want to know which part of your maintenance has come loose, the free two-minute check will tell you, and needs no email address.

If eating enough is the part you are stuck on

Eat Strong in Maintenance

The protein-first companion for a smaller appetite: the plate method, food guides with real portions, fifteen no-cook wins for low-energy days, and four weeks of tick-box trackers. No grams, no calorie counting. It is not a hair-loss treatment and it would be wrong to sell it as one. It makes one controllable part of this easier.

Get it — $17

Instant PDF download · 30-day money-back guarantee

Or get all four workbooks in the Complete System for $49, against $86 bought separately.

About this guide

Written by Samantha Munns. I am an independent creator writing from lived experience of GLP-1 weight loss and maintenance, not from clinical training. I am not a doctor, dietitian or pharmacist. Everything here is general information, checked against the sources listed below.

Published 27 July 2026. Last reviewed 27 July 2026. Next scheduled review January 2027, or sooner if regulatory guidance changes. This is a fast-moving area and the evidence on this page is dated deliberately so you can see how current it is.

Sources

  1. Tang H, Zhang B, Lu Y, et al. Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation. BMJ. 2026;394:e100077. doi.org/10.1136/bmj-2026-100077
  2. Science Media Centre. Expert reaction to a target trial emulation study on risk of hair loss associated with GLP-1 RAs in adults with type 2 diabetes, 22 July 2026. sciencemediacentre.org
  3. Electronic Medicines Compendium. Wegovy 2.4 mg FlexTouch solution for injection, Summary of Product Characteristics, section 4.8. medicines.org.uk
  4. Electronic Medicines Compendium. Mounjaro KwikPen solution for injection in pre-filled pen, Summary of Product Characteristics, section 4.8: tabulated list of adverse reactions, and description of selected adverse reactions, hair loss. medicines.org.uk
  5. ITV News. Weight loss drugs like Mounjaro and Wegovy linked to hair loss, researchers say, 22 July 2026. itv.com
  6. British Association of Dermatologists. Telogen effluvium, patient information leaflet. bad.org.uk
  7. NICE Clinical Knowledge Summaries. Female pattern hair loss: investigations. cks.nice.org.uk
  8. British Dietetic Association. Development of nutrition resources for people taking medications for obesity. bda.uk.com
  9. Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity. American Journal of Clinical Nutrition, 2025. ajcn.nutrition.org
  10. British Association of Dermatologists. Traction alopecia, patient information leaflet. bad.org.uk
  11. NIH Office of Dietary Supplements. Biotin, health professional fact sheet. ods.od.nih.gov
  12. US Food and Drug Administration. Biotin interference with troponin lab tests. fda.gov